Today we compared a new batch of Sofosbuvir and Ledipasvir to our reference sample data and found it consistent.
It’s reassuring to see the consistency.
Today we compared a new batch of Sofosbuvir and Ledipasvir to our reference sample data and found it consistent.
It’s reassuring to see the consistency.
